Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis-1 with Everolimus: A Phase II, Open-Label, Single-Arm Trial
Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis-1 with Everolimus: A Phase II, Open-Label, Single-Arm Trial
description
scientific article published on 01 December 2018
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2018
@uk
name
Treatment of Disfiguring Cutan ...... , Open-Label, Single-Arm Trial
@en
Treatment of Disfiguring Cutan ...... , Open-Label, Single-Arm Trial
@nl
type
label
Treatment of Disfiguring Cutan ...... , Open-Label, Single-Arm Trial
@en
Treatment of Disfiguring Cutan ...... , Open-Label, Single-Arm Trial
@nl
prefLabel
Treatment of Disfiguring Cutan ...... , Open-Label, Single-Arm Trial
@en
Treatment of Disfiguring Cutan ...... , Open-Label, Single-Arm Trial
@nl
P2093
P50
P1433
P1476
Treatment of Disfiguring Cutan ...... , Open-Label, Single-Arm Trial
@en
P2093
Adelaide A Hebert
Hope Northrup
John M Slopis
Joshua A Samuels
Keri C Smith
Octavio Arevalo
Patti Tate
P304
P356
10.1007/S40268-018-0248-6
P407
P577
2018-12-01T00:00:00Z